39-amino-acid dual-agonist, more complex than semaglutide but more established than retatrutide
Most cases are uncomfortable but not dangerous
In the Phase 2 obesity trial published in NEJM in 2023, retatrutide at the 12 mg weekly dose produced a mean placebo-adjusted body weight reduction of 22.1 percentage points (22.1% (24.2% arm) mean absolute reduction on the retatrutide arm) at 48 weeks (Jastreboff et al., NEJM, 2023)
KEY BENEFITS: Enhanced Fat Burning:L-Carnitine plays a crucial role in converting stored body fat into energy, helping you achieve a leaner physique faster
Store boxed Lipo Lab at least 10 cm (4 inches) from the back wall to avoid condensation points and ensure adequate air circulation
Seek urgent medical attention via NHS 111, A&E, or 999 if you experience: Very heavy bleeding with dizziness, fainting, or signs of shock Severe abdominal pain with bleeding Positive pregnancy test with severe pain or heavy bleeding Investigations for persistent menstrual irregularities may include: Pregnancy test (first line) Full blood count (to assess for anaemia) Thyroid function tests Hormonal profile (FSH, LH, oestradiol, prolactin, testosterone) Pelvic ultrasound scan if structural abnormalities are suspected Consideration of referral to gynaecology if symptoms persist or are severe Your GP can help determine whether menstrual changes are likely related to weight loss and metabolic improvements or whether further investigation is warranted